Cargando…
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease
Parkinson's disease is the second-most common neurodegenerative disorder worldwide. Besides deciphering the mechanisms that underlie the etiology of the disease, it is important to elucidate the factors that influence the efficacy of the treatment therapeutics. Levodopa, which remains the golde...
Autores principales: | van Kessel, Sebastiaan P., El Aidy, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803777/ https://www.ncbi.nlm.nih.gov/pubmed/31681153 http://dx.doi.org/10.3389/fneur.2019.01087 |
Ejemplares similares
-
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021) -
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
por: van Kessel, Sebastiaan P., et al.
Publicado: (2022) -
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2020)